- Nextool AI
- Posts
- Claude for $1?
Claude for $1?
Plus: AI in health is having a bad effect on doctors... here's more to learn about it
Today, we’re looking at Anthropic’s boldest strategic move yet: offering its Claude AI model to the U.S. government for just $1. We’re also looking at Rolls-Royce’s boldest pivot yet: using small nuclear reactors to power AI data centers.
In today’s post:
Anthropic just offered Claude to the U.S. for $1
Can Rolls-Royce power the AI future?
AI made doctors worse?
What’s Trending Today
Strategy
The AI race is now a bidding war and the bids are symbolic.

Anthropic, fresh off federal approval for Claude, is offering the AI model to the U.S. government for just $1. But this isn't a charity move, it’s a strategy.
Here’s everything you need to know:
Claude was recently added to the list of approved AI vendors for U.S. federal agencies.
Anthropic’s offer mirrors OpenAI’s, which also made ChatGPT Enterprise available for $1 per agency.
The symbolic price is a foothold, not a loss leader, but a relationship builder.
Access to government contracts means long-term influence, compliance trust, and deeper integration.
AI providers are racing not just for market share but for institutional adoption.
Federal use of AI models could shape regulatory norms and deployment standards.
The real prize isn't this $1 deal, it’s the data, visibility, and long-tail contracts that follow.
In this phase of AI, power doesn’t come from price. It comes from proximity to the institutions that will shape the rules. And right now, the smartest move might just be giving it away.
Kickstart your holiday campaigns
CTV should be central to any growth marketer’s Q4 strategy. And with Roku Ads Manager, launching high-performing holiday campaigns is simple and effective.
With our intuitive interface, you can set up A/B tests to dial in the most effective messages and offers, then drive direct on-screen purchases via the remote with shoppable Action Ads that integrate with your Shopify store for a seamless checkout experience.
Don’t wait to get started. Streaming on Roku picks up sharply in early October. By launching your campaign now, you can capture early shopping demand and be top of mind as the seasonal spirit kicks in.
Get a $500 ad credit when you spend your first $500 today with code: ROKUADS500. Terms apply.
Growth
Rolls-Royce thinks nuclear can make it the UK’s #1 company

Image Credits: The Guardian
Rolls-Royce isn’t just building engines anymore. It’s betting on nuclear reactors to power AI data centers and possibly to become the most valuable company in the UK.
Here’s everything you need to know:
The company has signed deals to build small modular reactors (SMRs) for AI data centers in the UK and Czech Republic.
CEO Tufan Erginbilgic says the energy demand from AI could drive Rolls-Royce to the top of the FTSE.
SMRs are faster and cheaper to build than traditional nuclear plants, but none are operational yet.
Major tech firms like Google and Meta have also lined up future SMR energy deals in the U.S.
Rolls-Royce already builds reactors for submarines and wants to be the market leader on land too.
There are concerns: water usage for cooling, unproven scalability, and massive upfront costs.
But with AI’s energy needs ballooning, nuclear may be one of the few scalable options left.
It’s rare to see a 100-year-old firm try to reinvent itself for the next industrial age, rarer still to pull it off. Rolls-Royce might be late to AI, but if it powers the infrastructure behind it, it won’t matter.
Breakthrough
AI tools boosted cancer detection… until they didn’t.

A new study reveals a hidden cost of AI in medicine: human skill decay. It’s not just a sci-fi scenario, it’s already happening in hospitals.
Here’s everything you need to know:
Researchers studied doctors using AI to detect precancerous colon growths.
While AI improved detection initially, doctors’ skills declined once the tool was removed.
Detection rates dropped 20% compared to pre-AI performance.
The study suggests rapid reliance on AI can erode baseline medical skills.
It raises questions about what happens when AI fails or is unavailable.
There's a fine line between assistance and dependence and medicine may be crossing it.
As AI integrates deeper into healthcare, training may need a rethink to preserve core skills.
We’re discovering that AI not only changes how work gets done, it changes who’s doing the real work. If we aren’t careful, we may automate away the very expertise we need most when tech falls short.
🚀 Founders & AI Builders, Listen up!
If you’ve built an AI tool, here’s an opportunity to gain serious visibility.
Nextool AI is a leading tools aggregator that offers:
500k+ page views and a rapidly growing audience.
Exposure to developers, entrepreneurs, and tech enthusiasts actively searching for innovative tools.
A spot in a curated list of cutting-edge AI tools, trusted by the community.
Increased traffic, users, and brand recognition for your tool.
Take the next step to grow your tool’s reach and impact.
That's a wrap:Please let us know how was this newsletter: |
Reach 140,000+ READERS:
Expand your reach and boost your brand’s visibility!
Partner with Nextool AI to showcase your product or service to 140,000+ engaged subscribers, including entrepreneurs, tech enthusiasts, developers, and industry leaders.
Ready to make an impact? Visit our sponsorship website to explore sponsorship opportunities and learn more!